---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-282889"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:39:15.234053+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics appoints Jeffrey Hessekiel as EVP, Chief Legal and Administrative Officer

## Summary
- Appointment effective Nov 14, 2025; Hessekiel previously EVP & General Counsel at Exelixis (2014-2025).
- Annual base salary of $660,000 and target bonus of 50% of base salary.
- Signing bonus of $400,000 payable 50% on first payroll cycle and 50% after one year.
- Initial RSU award of $5,800,000 grant-date value vests 40/40/20 over three years.
- Eligible for company benefit plans, 2004 Equity Incentive Plan, and Executive Severance Plan.

## SEC filing metadata
- accession: 0001193125-25-282889
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000119312525282889/0001193125-25-282889-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000119312525282889/cytk-20251113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-282889
- JSON: https://secwatch.observer/filing/0001193125-25-282889.json
- Plain text: https://secwatch.observer/filing/0001193125-25-282889.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.